Answers are grounded in this paper and cite their sources.
Mesenchymal stem cells (MSCs) now are popular stem cells for clinical applications. To date, MSCs were accepted in various disease treatments with several FDA approved treatments in some countries. One important requirement for the clinical usage of stem cells is the production of stem cells. Actually, the treatment efficacy of MSC transplantation depends on the quality of transplanted MSCs. This review aimed to present some guidelines for MSC production according to good manufacturing practice that helps to maintain the quality of stem cells from batch to batch as well as the clinical satisfaction.
No takes yet. Share an insight, caveat, or question.
Pham et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: